Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center
© 2024 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd..
BACKGROUND AND AIM: Lack of awareness disturbs proper care for hepatitis C virus (HCV) infections in patients undergoing surgery. We investigated the status of HCV screening, confirmation, and treatment in patients who underwent surgery.
METHODS: Patients who underwent surgery at a tertiary academic center between 2019 and 2021 were eligible for this retrospective study.
RESULTS: Between 2019 and 2021, 96 894 patients (40 121 males; 41.4%) who underwent surgery under general anesthesia were recruited. The median age of the participants was 55.0 years. Of the 83 920 (86.6%) patients who tested positive for anti-HCV antibodies, 576 (0.7%) showed positive results, with a higher proportion of patients with diabetes mellitus (32.6% vs 18.5%), hypertension (50.5% vs 28.6%), liver cirrhosis (13.2% vs 1.7%), and unfavorable laboratory test results when compared with those with negative results (all P < 0.05). HCV RNA was tested in 215 patients (37.3%), with a positivity rate of 20.5% (n = 44). Of the 44 patients, 42 (95.5%) were referred for antiviral treatment, and 29 (69.0%) were successfully treated with direct-acting antiviral therapy. HCV RNA confirmation rates were higher in the Department of Hepatobiliary and Transplant Surgery (76.6%) than in the other surgical departments (25.0-33.5%) (P < 0.001).
CONCLUSIONS: The proportion of patients who were positive for anti-HCV antibodies and failed to receive proper management after surgery was not negligible. Increased awareness of HCV infection among surgeons through appropriate education may be required.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Journal of gastroenterology and hepatology - (2024) vom: 15. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lee, Jae Seung [VerfasserIn] |
---|
Links: |
---|
Themen: |
Care cascade |
---|
Anmerkungen: |
Date Revised 15.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1111/jgh.16506 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368479366 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368479366 | ||
003 | DE-627 | ||
005 | 20240215232222.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240215s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/jgh.16506 |2 doi | |
028 | 5 | 2 | |a pubmed24n1294.xml |
035 | |a (DE-627)NLM368479366 | ||
035 | |a (NLM)38357836 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lee, Jae Seung |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 15.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. | ||
520 | |a BACKGROUND AND AIM: Lack of awareness disturbs proper care for hepatitis C virus (HCV) infections in patients undergoing surgery. We investigated the status of HCV screening, confirmation, and treatment in patients who underwent surgery | ||
520 | |a METHODS: Patients who underwent surgery at a tertiary academic center between 2019 and 2021 were eligible for this retrospective study | ||
520 | |a RESULTS: Between 2019 and 2021, 96 894 patients (40 121 males; 41.4%) who underwent surgery under general anesthesia were recruited. The median age of the participants was 55.0 years. Of the 83 920 (86.6%) patients who tested positive for anti-HCV antibodies, 576 (0.7%) showed positive results, with a higher proportion of patients with diabetes mellitus (32.6% vs 18.5%), hypertension (50.5% vs 28.6%), liver cirrhosis (13.2% vs 1.7%), and unfavorable laboratory test results when compared with those with negative results (all P < 0.05). HCV RNA was tested in 215 patients (37.3%), with a positivity rate of 20.5% (n = 44). Of the 44 patients, 42 (95.5%) were referred for antiviral treatment, and 29 (69.0%) were successfully treated with direct-acting antiviral therapy. HCV RNA confirmation rates were higher in the Department of Hepatobiliary and Transplant Surgery (76.6%) than in the other surgical departments (25.0-33.5%) (P < 0.001) | ||
520 | |a CONCLUSIONS: The proportion of patients who were positive for anti-HCV antibodies and failed to receive proper management after surgery was not negligible. Increased awareness of HCV infection among surgeons through appropriate education may be required | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a care cascade | |
650 | 4 | |a early diagnosis | |
650 | 4 | |a hepatitis C virus | |
650 | 4 | |a hepatitis C, chronic | |
650 | 4 | |a screening | |
700 | 1 | |a Lee, Hye Won |e verfasserin |4 aut | |
700 | 1 | |a Kim, Mi Na |e verfasserin |4 aut | |
700 | 1 | |a Kim, Beom Kyung |e verfasserin |4 aut | |
700 | 1 | |a Park, Jun Yong |e verfasserin |4 aut | |
700 | 1 | |a Kim, Do Young |e verfasserin |4 aut | |
700 | 1 | |a Ahn, Sang Hoon |e verfasserin |4 aut | |
700 | 1 | |a Kim, Seung Up |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of gastroenterology and hepatology |d 1989 |g (2024) vom: 15. Feb. |w (DE-627)NLM012635235 |x 1440-1746 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:15 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/jgh.16506 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 15 |c 02 |